Neuroone Medical Technologies (NMTC) Total Liabilities (2010 - 2026)

Neuroone Medical Technologies' Total Liabilities history runs 17 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• Quarterly Total Liabilities fell 25.2% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 25.2% YoY) and the FY2025 annual result came in at $3.7 million, down 18.36% from the prior year.
• Total Liabilities was $2.5 million for Q1 2026 at Neuroone Medical Technologies, up from $2.2 million in the prior quarter.
• Across five years, Total Liabilities topped out at $4.5 million in Q3 2024 and bottomed at $952478.0 in Q2 2022.
• A 5-year average of $2.3 million and a median of $1.9 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2023 — Total Liabilities slumped 42.58% — and 2024, when it jumped 153.46%.
• Neuroone Medical Technologies' Total Liabilities stood at $1.5 million in 2022, then dropped by 5.66% to $1.4 million in 2023, then soared by 153.46% to $3.6 million in 2024, then tumbled by 38.87% to $2.2 million in 2025, then increased by 14.51% to $2.5 million in 2026.
• Business Quant data shows NMTC's Total Liabilities at $2.5 million in Q1 2026, $2.2 million in Q4 2025, and $3.7 million in Q3 2025.